Skip to content
S7194Senate2021-2022 SessionSame asA6395

Use Opioid Settlement Funds Locally

Official title

“Requires funds from opioid settlements to be used for the development of new services and supports”

Sponsor Gustavo RiveraSD-33+5 co-sponsorsAffects Finance
Status
Signed by Governor
Impact
9/10
Transformational
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill establishes the Opioid Settlement Fund, directing opioid litigation settlement money to substance use disorder prevention, treatment, recovery, and harm reduction programs in New York.

Why it matters

  1. Guarantees “new money” for opioid response. The bill requires that settlement funds must supplement—not replace—existing federal, state, or local funding for substance use disorder prevention, treatment, recovery, and harm reduction. This ensures that the settlement money leads to expanded services, not just filling budget gaps.

  2. Prioritizes evidence-based and culturally competent programs. Funding decisions must focus on programs that are effective, trauma-informed, and tailored to the cultural, linguistic, and gender needs of New York’s diverse communities. Programs that employ people with lived experience of addiction are also prioritized, aiming to improve outcomes and equity.

  3. Creates strong oversight, transparency, and regional equity. The law establishes a diverse advisory board to recommend how funds are spent, requires annual public reporting on spending and outcomes, and mandates regional distribution of funds. This is designed to prevent misuse, promote accountability, and ensure resources reach communities most affected by the opioid crisis across the state.

  4. Prevents future lawsuits against settled entities. Once an opioid manufacturer, distributor, or similar company settles with the state, government entities (like counties or cities) are barred from bringing new lawsuits over the same claims. This provision provides legal finality for settling parties and ensures all settlement funds are coordinated through the state process.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Use Opioid Settlement Funds Locally

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Gustavo Rivera

Senator · Senate District 33

Chair, Health

History

  1. Approval memo.10
  2. Signed chap.190
  3. Delivered to governor
  4. Returned to senate
  5. Passed assembly
  6. Ordered to third reading rules cal.665
  7. Substituted for A6395B
  8. Referred to ways and means
  9. Delivered to assembly
  10. Passed senateVote 63–0
  11. Ordered to third reading cal.1612
  12. Referred to rules

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A6395Assembly

Use Opioid Settlement Funds Wisely

Assembly Floor Calendar · Sponsor Carrie Woerner

Impact 8 · Significant0% to pass

Full text

8 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

7194

2021-2022 Regular Sessions

IN SENATE

June 5, 2021

Introduced by Sens. RIVERA, HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to amend the state finance law, the mental hygiene law, and the executive law, in relation to establishing an opioid settlement fund

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The state finance law is amended by adding a new section 99-nn to read as follows:

§ 99-nn. Opioid settlement fund. 1. There is hereby established in the joint custody of the state comptroller and the commissioner of taxation and finance a special fund to be known as the "opioid settlement fund".

2. Money allocated to the opioid settlement fund shall be kept separate and shall not be commingled with any other funds in the custody of the state comptroller.

3. Money expended from such fund shall be used to supplement and not supplant or replace any other funds, including federal or state funding, which would otherwise have been expended for substance use disorder prevention, treatment, recovery or harm reduction services or programs. Provided further, general operating funds or baseline funding shall not be reduced due to monies expended from the fund.

4. Such fund shall consist of money received by the state as a result of the settlement of litigation with entities that manufactured, sold, distributed, dispensed or promoted opioids, made in connection with claims arising from the manufacturing, marketing, distributing, promoting or dispensing of opioids, as well as any funds received by the state as a result of a judgment, stipulation, decree, agreement to settle, assurance of discontinuance, or other legal instrument resolving any claim or cause of action against manufacturers, distributors, dispensers or vendors of opioids and related entities arising out of activities alleged to have contributed to increases in opioid addiction, whether filed or unfiled, actual or potential, and whether arising under common

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD10289-21-1

S. 7194 2

law, equity, or any provision of law, and all other monies appropriated, credited, or transferred thereto from any other fund or source pursuant to law. All monies shall remain in such fund unless and until directed by statute or appropriation.

5. Notwithstanding subdivision eleven of section four of this chapter, or subdivision sixteen of section sixty-three of the executive law, monies from the opioid settlement fund shall be available following appropriation by the legislature and shall only be expended on eligible expenditures as defined in section 25.18 of the mental hygiene law for prevention, treatment, harm reduction and recovery services related to substance use disorders and co-occurring mental illnesses in New York state pursuant to the terms of the statewide opioid settlement agreements as defined in section 25.18 of the mental hygiene law. Funding shall be distributed regionally and to ensure adequate geographic disbursement across the state in accordance with the statewide opioid settlement agreements. In addition to programs and services overseen by the office of addiction services and supports, funding may also be expended on programs and services overseen by the department of health, the office of mental health, the division of housing and community renewal or any other agency that may oversee an appropriate program or service that is considered an eligible expenditure as provided under section 25.18 of the mental hygiene law. Funding decisions shall include an emphasis on supporting programs that are culturally, linguistically and gender competent, trauma-informed, evidence-based and, where appropriate, employ individuals with lived experience as part of the services provided.

§ 2. The mental hygiene law is amended by adding a new section 25.18 to read as follows: § 25.18 Statewide opioid settlements.

(a) Definitions. As used in this section, the following terms shall have the following meanings: 1. Eligible expenditures shall include services and programs that are consistent with the approved uses and terms of the statewide opioid settlement agreement and include but not be limited to, programs:

(i) to prevent substance use disorders through an evidence-based youth-focused public health education and prevention campaign, including school-based prevention and health care services and programs to reduce the risk of substance use by school-aged children;

(ii) to develop and implement statewide public education campaigns to reduce stigma against individuals with a substance use disorder, provide information about the risks of substance use, best practices for addressing substance use disorders, and information on how to locate services that reduce the adverse health consequences associated with substance use disorders or provide treatment for substance use disorders;

(iii) to provide substance use disorder treatment and early recovery programs for youth and adults, with an emphasis on programs that provide a continuum of care that includes screening and assessment for substance use disorders and co-occurring disorders, active treatment, family involvement, case management, relapse management for substance use and other co-occurring behavioral health disorders, vocational services, literacy services, parenting classes, family therapy and counseling services, crisis services, recovery services, evidence-based treatments, medication-assisted treatments, including medication assisted treatment provided in correctional facilities, psychiatric medication, psychotherapy and transitional services programs;

S. 7194 3

(iv) to provide harm reduction counseling and services to reduce the adverse health consequences associated with substance use disorders, including overdose prevention and prevention of communicable diseases related to substance use, provided by a substance use disorder service provider or qualified community-based organization;

(v) to provide housing services for people who are recovering from a substance use disorder. Such housing services shall be appropriate, based on the individual's current need and stage of recovery. Such housing services may include but are not limited to supportive housing services;

(vi) to support community-based programs that reduce the likelihood of criminal justice involvement for individuals who have or are at risk of having a substance use disorder;

(vii) to provide programs for pregnant women and new parents who currently or formerly have had a substance use disorder and newborns with neonatal abstinence syndrome; and

(viii) to provide vocational and educational training for individuals with or at risk for a substance use disorder.

2. "Government entity" means (i) departments, agencies, divisions, boards, commissions and/or instrumentalities of the state of New York including, the department of financial services, the superintendent of the department of financial services, and the New York liquidation bureau, provided however it shall not include the department of law; and

(ii) any governmental subdivision within the boundaries of the state of New York, including, but not limited to, counties, municipalities, districts, towns and/or villages, and any of their subdivisions, special districts and school districts, and any department, agency, division, board, commission and/or instrumentality thereof.

3. "Participating entities" means participating entities as such term is defined in any statewide opioid settlement agreement.

4. "Opioid settlement fund" means the fund created by the statewide opioid agreements and section ninety-nine-nn of the state finance law, the funds of which shall be used or distributed by the commissioners, as authorized by the legislature by statute or appropriation, for the purposes of preventing addiction and reducing the harms caused by the overdose and substance use disorder epidemic consistent with the terms of any statewide opioid settlement agreement.

5. "Released claims" means released claims as such term is defined in the statewide opioid settlement agreements.

6. "Released entities" means released entities as such term is defined in the statewide opioid settlement agreements.

7. "New York subdivisions" means each county, city, town, village, or special district in the state of New York.

8. "Statewide opioid settlement agreements" means agreements of statewide applicability, including but not limited to consent judgments, consent decrees filed or unfiled, and related agreements or documents between the state and certain opioid manufacturers, distributors, dispensers, consultants, chain pharmacies, related entities, and/or the New York subdivisions, to provide remuneration for conduct related to the manufacture, promotion, dispensing, sale, and/or distribution of opioid products. Copies of such agreements, including any amendments thereto, shall be kept on file by the attorney general, who shall make such available for inspection and copying pursuant to the provisions of article six of the public officers law.

(b) Eligible expenditures for opioid settlement funds. 1. The legislature shall appropriate funds to be used for eligible expenditures that

S. 7194 4

are consistent with the approved uses and terms of the statewide opioid settlement agreement. Such expenditures shall be distributed regionally and in accordance with the statewide opioid settlement agreements to ensure adequate geographic disbursement across the state.

2. New York subdivisions shall apply to the appropriate agency for funding for eligible expenditures consistent with the terms of any statewide opioid settlement agreement. Any New York subdivision which receives funding pursuant to this section shall be required to annually certify to the appropriate state agency in which funding was received that such New York subdivision is utilizing such funds in accordance with the requirements of this section and section ninety-nine-nn of the state finance law.

3. Each New York subdivision shall provide a detailed accounting of how the funds were used as well as an analysis and evaluation of the services and programs funded. Such information shall be included in the report provided pursuant to paragraph ten of subdivision (c) of this section.

(c) Advisory board establishment and responsibilities. 1. The opioid settlement board is hereby established under the office of addiction services and supports to provide recommendations on how funding received by the opioid settlement fund pursuant to section ninety-nine-nn of the state finance law shall be allocated by the legislature. Recommendations shall be evidenced-based and may take into consideration federal, state or local initiatives and activities that have shown to be effective in preventing and treating substance use disorders as well as maintaining recovery and assisting with the collateral effects of substance use disorders for individuals and their families or support system. Such recommendations shall also take into account any gaps in access to services or programs identified as eligible expenditures and incorporate mechanisms for measurable outcomes for determining the effectiveness of funds expended. The office and any other relevant agency that provides or regulates eligible expenditures shall provide any necessary staff, resources and technical assistance to assist with the functions of the advisory board. Such assistance shall be supported pursuant to an appropriation by the legislature, in accordance with the statewide opioid settlement agreements.

2. The opioid settlement board may make recommendations to the legislature regarding the addition or removal of any eligible expenditures in response to changing substance use disorder needs in the state. No recommendation may be made to remove an eligible expenditure without three-fourths approval of present board members.

3. The opioid settlement board shall consist of nineteen members appointed as follows:

(i) the commissioner of addiction services and supports, the commissioner of mental health, and the commissioner of health, or their designees, serving as ex-officio non-voting members;

(ii) two appointments by the governor;

(iii) two appointments by the temporary president of the senate;

(iv) two appointments by the speaker of the assembly;

(v) two appointments by the attorney general;

(vi) one appointment by the mayor of the city of New York; and

(vii) seven appointments from a list of nominees submitted, pursuant to a statewide opioid settlement agreement, by an association of counties that represents at least ninety percent of the counties in New York, counting both by number of counties and by population at the time such statewide opioid settlement agreement was finalized. Such appoint-

S. 7194 5

ments shall be selected as follows: two from the temporary president of the senate, two from the speaker of the assembly, one from the minority leader of the senate, one from the minority leader of the assembly and one from the attorney general.

4. Each member shall be appointed to serve three-year terms and in the event of a vacancy, the vacancy shall be filled in the manner of the original appointment for the remainder of the term. The appointed members and commissioners shall receive no compensation for their services but shall be allowed their actual and necessary expenses incurred in the performance of their duties as board members.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the state finance law, the mental hygiene law, and the executive law, in relation to establishing an opioid settlement fund

Purpose

To establish an opioid settlement fund and advisory board to insure that any settlement monies are dedicated towards substance use disorder prevention, treatment and recovery.

Summary of provisions

Section 1 establishes the opioid settlement fund: in the joint custody of the comptroller and the commissioner of taxation and finance and outlines how the monies in such fund shall be appropriated consistent with the terms of any statewide opioid settlement agreements for eligi- ble expenditures.

Read the full memo (839 words)

Section 2 provides definitions and creates an advisory board to make recommendations to the legislature for appropriation of moneys from the opioid fund and requires public reporting of how the funding has been spent. In addition, no government entities can bring lawsuits against entities that have been released by the Attorney General's office as part of the settlement.

Section 3 requires the Office of Addiction Services and Supports, in consultation with the office of mental health, the division of housing and community renewal, and other agency that oversees programs to moni- tor and ensure funds appropriated are expended for appropriate services.

Section four ensures that funds received by the State through opioid settlement agreements can be expended by State Agencies.

Section five excludes funds received by the State through opioid settle- ment agreements from being deposited into the State's General Fund.

Section 6 provides an effective data.

Justification

Even prior to the COVID-19 pandemic, New York, like much of the country, had been ravaged by the overdose epidemic. In 2018 alone, over 3,000 New Yorkers died from overdoses involving opioids. Many thousands of others overdosed without dying. While these numbers are lower than in 2017, anecdotal evidence suggests that the isolation, loss of housing and jobs, and other psychological consequences of COVID-19 are resulting in a dramatic increase in substance use disorders, overdose and death. Furthermore, the focus on overdose and deaths ignores the wide array of other human and financial impacts of opioid use, from the increased need for treatment services to an expansion in criminal, legal and child welfare systems involvement. Yet, programs that address the needs of individuals who use drugs, including those providing prevention, harm reduction, mental health, substance use disorder treatment, housing and other services, have been struggling for years from budget cuts and increased costs. Now, as New York needs to respond to another rise in drug use, overdoses and deaths, the state and local budget cuts result- ing from the pandemic will cause many of these programs to reduce services or even close down altogether. This will only exacerbate the human and financial impact of both the overdose epidemic and the COVID- 19 pandemic.

While a number of factors helped cause the overdose epidemic, one significant element was the huge increase in prescribing of opioid medi- cations that began in the 1990s. Yet, for years, the corporations that manufactured, distributed, and sold these drugs willfully ignored or misrepresented the impact of these medications and the extent of the problem. To hold them accountable for their actions and to address the huge budgetary impact of the substance use disorder problems that they helped to cause, New York, along with other states and localities, have brought a number of lawsuits and other enforcement actions against these entities. Lawsuits and large settlements awarded to address a public health crisis is not new. In 1998, New York and 45 other states settled lawsuits with the four largest tobacco manufacturers in the United States who agreed to pay over $200 billion over the course of 25 years. This money was intended to help these states cover the financial cost caused by the health and other consequences of tobacco. Yet, contrary to the lawsuits' goals, many states ended up using their tobacco settlement money to pay for an array of programs and services unrelated to the harms of tobacco use.

The lawsuits and enforcement actions that New York is currently taking against manufacturers and distributors of opioids could result in the State receiving millions of dollars. Any money obtained from these lawsuits must be used to address the harms caused by drug use and by the ways in which drug laws have been enforced. Ensuring that the money is used in this way is especially important now, as the need for services is increasing and the programs providing these services are struggling to survive under years of budget cuts and new looming cuts threatened to make up for budget shortfalls in the midst of the COVID-19 pandemic.

This bill creates a secure fund for any opioid settlement funds the state receives and board to oversee the fund allocations. It ensures that dollars received in any settlement are used for the intended and right purposes.

Legislative history

New bill.

Fiscal implications for state and local governments

None to state - all monies in the fund are derived from settlements.

Effective date

Immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.